Navigation Links
Tick Population Growth Increases Tick-Borne Disease Risk in 2013
Date:7/30/2013

ST. JOSEPH, Mo., July 30, 2013 /PRNewswire/ -- With the summer months upon us, Lyme disease and other tick-borne illnesses are on the rise in the United States. According to the U.S. Centers for Disease Control and Prevention (CDC), tick-borne diseases are increasing, with human cases expected to exceed 300,000 annually1.

(Photo: http://photos.prnewswire.com/prnh/20130730/CG54900)

(Logo: http://photos.prnewswire.com/prnh/20120925/CG80722LOGO)

Veterinary experts agree pet owners should be on high alert this year, as the threat of disease expands geographically and companion animals are progressively more at risk of coming into contact with ticks and Lyme disease.

"Although some regions continue to be considered endemic with greater levels of exposure, and some regions have a low risk of exposure, Lyme disease-infected dogs have now been found in all 48 contiguous states. There are many diseases spread by ticks and our dogs can get more than one at a time. With more ticks in more locations, we're finding that more of these diseases are being transferred to our dogs," said Mike Paul, DVM. "Due to climate change and wildlife coming further into suburban environments, ticks are really a huge problem throughout all of North America. Pet owners need to understand that ticks pose a serious threat."

The CDC has singled out Lyme disease in people as the most common and fastest growing vector-borne, infectious disease in the country. Due to increased numbers of ticks in recent years, Lyme has become a growing concern for veterinary practitioners and dog owners2.

As the tick population increases, it's vital that pet owners are educated on Lyme disease dangers for canines. Pet owners should visit LymeInfo.com, an enhanced website featuring up-to-date information on canine Lyme disease, clinical symptoms, disease transmission, risk factors, tick-specific data and how pet owners can prevent the spread of disease. LymeInfo.com also provides education on Lyme disease prevention, including vaccines and tick control.

"With an increasing number of ticks across the U.S., the very best approach for every dog is prevention. Since there is an effective vaccine for Lyme disease, it is advisable to prevent this disease rather than to rely on treating infected animals," said Carrie White, DVM, DACVIM, Internist at VCA Family Animal Hospital in Pearl City, Hawaii. "Disease prevention can save pets and their owners a great degree of financial and emotional distress."

Make Lyme-disease prevention a priority for your dog, and visit LymeInfo.com for more information on Lyme disease in your area.

1 Lyme Disease Association

2 Steven Levy, VMD. Use of a C6 ELISA Test to Evaluate the Efficacy of a Whole-Cell Bacterin for the Prevention of Naturally Transmitted Canine Borrelia Burgdorferi Infection. Veterinary Therapeutics, Volume 3. No. 4, Winter 2002.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavours.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales.

For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.


'/>"/>
SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan: SMBG Suppliers Look to Tap the Huge Underpenetrated Diabetic Population in Asia-Pacific
2. The World Customs Organization (WCO) and the Institute of Research Against Counterfeit Medicines (IRACM) issue a new warning about the health and safety of African populations
3. Allscripts dbMotion Population Health Forum Reveals that Move to Population Health Management Adoption is Happening "Much Faster than Anyone Expected"
4. Approval for One Neuropathic Pain Indication is Sufficient to Support Physician Prescribing and Payer Reimbursement Across Multiple Neuropathic Pain Populations
5. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
6. Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
7. Class III Obese Patients Experience Adverse Events More Frequently Than the General Adverse Event Patient Population
8. EU5 Nephrologists Report a Decreasing Trend in the Treatment Prevalence of ESAs in the Haemodialysis Patient Population
9. EU5 Nephrologists Report a Stabilization of Phosphate Binder Treatment Prevalence in the Late-Stage CKD and Dialysis Patient Populations
10. Affluence, an Aging Population, and Anticipated Rx-to-OTC Switches Boost a Healthy $32 Billion OTC Market in China, According to Kline
11. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... May 5, 2016 ... addition of the  "Europe Thrombocytopenia Market ...  report to their offering.  ... , ,The latest research Europe Thrombocytopenia ... 2016, provides comprehensive insights into Thrombocytopenia ...
(Date:5/4/2016)... -- Compass Diversified Holdings (NYSE: CODI ) ("CODI," ... middle market businesses, announced today its consolidated operating results ... First Quarter 2016 Highlights , Generated Cash ... Flow") of $13.6 million for the first quarter of ... for the first quarter of 2016; , Paid ...
(Date:5/4/2016)... Israel , May 4, 2016 ... that BiondVax,s CEO, Dr. Ron Babecoff , will be ... New York City . On Thursday, May ... 2016, a conference presented by Joseph Gunner & ... The BiondVax presentation that Dr. Babecoff will be using ...
Breaking Medicine Technology:
(Date:5/6/2016)... PA and LONDON, UK (PRWEB) , ... May 06, 2016 , ... ... accolades for his success in changing the way the pharmaceutical industry conducts clinical trials. ... of the world’s most influential people in pharma, and he was honored as a ...
(Date:5/6/2016)... ... May 06, 2016 , ... Bluvault ( Bluvault Inc. ) ... for global clients of Coupa ( Coupa Software ) and other Cloud software, ... a key component in the suite of innovative implementation services offered by Bluvault. ...
(Date:5/6/2016)... ... May 06, 2016 , ... From May 4 to 6, ... members the unique opportunity to learn more about Signia’s technology and the successful business ... “It is our priority to see practices succeed in this highly competitive industry,” said ...
(Date:5/6/2016)... ... May 06, 2016 , ... Multiple award winning plumbing ... for over 35 years. Maintaining core values of exceptional customer service, quality work at ... them a leading name in San Diego plumbing, and other services including heating & ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... David Konur, CEO of Cardiovascular Institute of the South announced today that Dr. ... a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. , ...
Breaking Medicine News(10 mins):